The Art of Submental Contouring: Novel Treatment Approaches for Total Facial Rejuvenation

The Art of Submental Contouring Novel Treatment Approaches for Total Facial Rejuvenation
Details
Download PDF
  • Overview

    This continuing medical education (CME) activity captures content from a roundtable discussion held in March 2017. This certified CME activity is designed for dermatologists and cosmetic surgeons. Balanced facial proportions reflected in ancient and classical art have not changed significantly over millennia, and they guide aesthetic physicians today. While fillers and neurotoxins can be used to remodel the mid-face non-invasively, the effects of chin dimensions and submental fullness have been difficult to modify without invasive surgical measures. Furthermore, in keeping with trends that focus on holistic approaches to aesthetic treatment, cosmetic surgeons are interested in treating submental fat within a regimen that also includes injectables and device-based interventions for pan-facial rejuvenation.This continuing medical education activity is supported through an educational grant from Allergan plc.
  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Discuss ideal proportions of facial anatomy and the affects of submental fullness on the individual’s appearance.

    • Articulate the method of action of deoxycholic acid and identify its role in the management of submental fat.

    • Identify ideal treatment parameters for deoxycholic acid injection that optimize patient comfort and long-term outcomes.

    • Determine optimal strategies for use of deoxycholic acid along with other interventions that target submental fullness.

    • Describe effective strategies that incorporate targeted treatment of the submentum into a pan-facial rejuvenation strategy.

  • Accreditation

    ACCREDITATION STATEMENT

    Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians.

    AMA CREDIT DESIGNATION STATEMENT

    Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Faculty and Disclosures

    DISCLOSURE POLICY
    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

    DISCLOSURE POLICY STATEMENT

    It is the policy of Evolve Medical Education LLC that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve Medical Education LLC has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

    The following faculty members have the following financial relationships with commercial interests:

    Steven Dayan, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan plc.; Kythera Biopharmaceuticals; L'Oreal; Medicis Pharmaceutical Corporation; Merz Aesthetics; and Sente.

    Mathew Avram, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Cytrellis Biosystems, Inc.; Merz Aesthetics; Sciton, Inc.; and ZELTIQ Aesthetics Inc. Grant/Research Support: Allergan plc; Cutera, Inc.; Invasix Ltd.; and ZELTIQ Aesthetics Inc. Stock/Ownership: Cytrellis Biosystems, Inc.; and Invasix Ltd.

    Deborah Sherman, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan plc; Galderma USA; and Obagi Medical Products.

    Sachin Shridharani, MD has had no financial agreements or affiliations during the past year.

    EDITORIAL SUPPORT DISCLOSURES

    Cheryl Cavanaugh, MS, Evolve Medical Education LLC, and Anthony Rossi, MD, Peer Reviewer, have no real or apparent conflicts of interest to report.

  • Disclaimer

    OFF-LABEL STATEMENT

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

    DISCLAIMER

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC and Allergan Inc.

    Distributed with: Modern Aesthetics®

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Expiration Date:

1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying Evolve Medical Education…
but how about a more personalized experience?

Register for free